Skip to main content
. 2018 Apr 16;6:e4667. doi: 10.7717/peerj.4667

Table 3. Statements receiving agreement of  >70% from Round Two and Three of Delphi.

Category Statement Agreement
Flexible pes planus determination; Visual assessment of dynamic foot in gait 85.7%
Dynamic WB and non-WB foot motion and/or measures 85.7%
Static foot posture measures; Foot Posture Index 6 (FPI-6) 100%
Foot function determination in paediatric flexible pes planus; Neurological assessments (Reflexes, sensation, tone and strength) 78.5%
Single Limb Balance 71.4%
The Balance tests to assess foot function; Hopping (n = dominant and non-dominant leg) 78.5%
Timed balance, standing on one leg (eyes open & closed) 85.7%
All balance tests for comprehensive assessment of functional impact rather than pes planus presence 100%
Walk along straight line/marching/heel-toe gait (forwards and backwards) 78.5%
Running 78.5%
Jumping 71.4%
Likeliness of FOs prescription for paediatric flexible pes; If dynamic foot function affected (instability in single leg stance, walking, running, turning, etc.) 85.7%
In presence of symptoms (pain, reduced function, strength and structure per WHO-ICD) 100%
In presence of structural changes (hallux abducto valgus, hallux limitus, etc.) 71.4%
With foot posture related delayed milestones 78.5%
With parental concern, accompanied by affected function 78.5%
With gross pronation (apropulsive gait and low tone) 100%
With hereditary lower limb disorder/s changing function and causing pain 92.8%
If improvement in ICF (The International Classification of Functioning, Disability and Health) outcomes 71.4%
Symptoms (e.g., pain, general discomfort, reduced walking, poor endurance and balance) 100%
Plantar arch/fascia pain 92.8%
Heel pain 78.5%
Tibialis Posterior tendon pain 100%
Medial Tibial Stress Syndrome (MTSS) type symptoms 100%
Activity related pain 92.8%
Regarding child’s age, decision of FOs use is influenced by: Other factors than age as extent/degree of deformity, type and frequency of activity, and function 92.8%
Acquisition of motor skills rather than age 71.4%
FOs preferred, in: Presence of symptoms (foot and leg pain, affected function and gross motor skill development) 92.8%
The aim of prescribing FOs is to: Reduce symptoms 92.8%
Reduce fatigue 85.7%
Improve gross motor skill 85.7%
Improve balance, stability, comfort, coordination, stamina and endurance 92.8%
Improve overall wellbeing and health outcomes per WHO-ICF, thus improved quality of life 71.4%
When comparing pre-fabricated FOs to custom-made FOs; Pre-fabricated FOs are easily modifiable 78.5%
Pre-fabricated FOs are cost effective 71.4%
Pre-fabricated FOs should be used when they offer enough control 71.4%
Customised FOs should be used if pre-fabricated FOs do not provide adequate support for the child’s foot 100%
Pre-fabricated FOs can be quickly dispensed i.e., as soon as the parents decide to use them 78.5%
The features that guide the choice of prefabricated FOs specific may include: Easy fit in a shoe 71.4%
Smooth contours (low irritation and increased comfort) 71.4%
Material easily customised 71.4%
Appropriate material strength to provide needed control 85.7%
Financial limitation of parents/cost 71.4%
Size availability 78.5%
For Custom FOs, a Medial (Kirby) heel skive may be used: To provide additional/better rearfoot control 78.5%
To help reduce STJ pronation 85.7%
In severe pes planus in the frontal plane 71.4%
For custom FOs, a UCBL (i.e., Medial and Lateral flange) device may be used: In grossly pronated feet with hypotonia 71.4%
When extra mid foot control is required in transverse plane 92.8%
For custom FOs, a medial flange device may be used: When extra midfoot control is required 92.8%
To limit MTJ pronation and prevent foot rolling over device 78.5%
In very flexible pes planus where medial edge of device is not tolerated 71.4%
Shell materials for Custom FOs; Three-dimensional printing materials 71.4%
Alternative devices for flexible pes planus; Rearfoot or heel wedges/lifts 71.4%
Exercise therapy 85.7%
For custom FOs, consider; Adequate accommodation of talo-navicular region to prevent blistering by wider midfoot area in device 71.4%

Notes.

WB
Wight bearing
WHO-ICD
World Health Organisation-International Classification of Diseases
STJ
Subtalar joint
MTJ
Midtarsal joint
UCBL
University of California Biomechanics Laboratory